NCT05173337 is a NA clinical trial of Nefopam in Lung Cancer, sponsored by Kangbuk Samsung Hospital.

Who is sponsoring NCT05173337?

NCT05173337 is sponsored by Kangbuk Samsung Hospital.

What drugs are being tested in NCT05173337?

Interventions in NCT05173337: Nefopam.

What condition does NCT05173337 study?

NCT05173337 studies Lung Cancer.

Is NCT05173337 still recruiting?

NCT05173337 is currently completed. Last updated 14 February 2023.

Last reviewed 2023-02-14 · How we verify

NCT05173337

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nefopam as a Multimodal Analgesia for Thoracic Surgery

Completed NA Last updated 14 February 2023

What this trial tests

NA trial testing Nefopam in Lung Cancer in 46 participants. Completed in 23 September 2022.

Timeline

8 December 2021

Primary endpoint
23 September 2022

23 September 2022

Quick facts

Lead sponsor	Kangbuk Samsung Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	prevention
Enrollment	46
Start date	8 December 2021
Primary completion	23 September 2022
Estimated completion	23 September 2022
Sites	1 location across South Korea

Drugs / interventions tested

Nefopam (NEFOPAM) — full drug profile →

Conditions studied

Lung Cancer — all drugs for Lung Cancer →

Sponsor

Kangbuk Samsung Hospital

Who can join

18 and older, any sex, with Lung Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acute postoperative pain after video-assisted thoracoscopic surgery is very severe. Because pain after thoracic surgery prevents early recovery, and increases postoperative complications, its is important to prevent pain after video-assisted thoracoscopic surgery. In the present study, we will evaluate whether nefopam reduces pain after video-assisted thoracoscopic surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Nefopam as a multimodal analgesia in thoracoscopic surgery: a randomized controlled trial.
Ki HS, Shim JG, Choi HK, Ryu KH, et al · · 2024 · PMID 38983158 · DOI 10.21037/jtd-24-30

Verify or expand the search:

Other trials of Nefopam

Trials testing the same drug.

NCT06627816 — Efficacy of Intravenous Nefopam, Dexmedetomidine, and Meperidine in Preventing Post-Spinal Anesthesia Shivering in Adult · NA · completed
NCT04685577 — Safety, Tolerability and Efficacy of Nefopam Cream in Burn Patients · Phase 2 · completed
NCT05071352 — Adjuvant Continuous Infusion of Nefopam Versus Standard of Care in Mechanically Ventilated Critically Ill Patients: Rand · Phase 3 · completed
NCT02577068 — Combination Effect of Nefopam With Propacetamol for Postoperative Pain After Thyroidectomy · NA · completed
NCT01882530 — Non-opioid Analgesic Combination With Morphine for Postoperative Analgesia. · Phase 4 · terminated

Other recruiting trials for Lung Cancer

Currently open trials in the same condition.

NCT07295821 — Osimertinib Induction and Maintenance for Chemo-ineligible Stage III Unresectable EGFR+ NSCLC: Single-arm Study · Phase 2 · recruiting
NCT06909201 — Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigatin · Phase 1 · recruiting
NCT07524114 — Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception · recruiting
NCT07487064 — Galvanize Aliya® EX Pulsed Electric Field (PEF) Treat and Resect Study · NA · recruiting
NCT07146568 — Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hos · NA · recruiting

Other Kangbuk Samsung Hospital trials

Trials by the same sponsor.

NCT07396961 — Consistency of ASIS Line vs. Tuffier's Line for Lumbar Level Identification · not yet recruiting
NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
NCT06773585 — Investigations of Factors Associated With Treatment Response and Prognosis in Anxiety Disorders · not yet recruiting
NCT06130137 — Gut Microbiome in People Living With HIV and HBV · not yet recruiting
NCT05538741 — Hypotension After Anesthetic Induction with Remimazolam in Elderly · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05173337 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kangbuk Samsung Hospital
Last refreshed: 14 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05173337.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing